BioPharma

Everest Medicines Announces Major Regulatory Updates in Taiwan and South Korea

-- Taiwan Food and Drug Administration grants Accelerated Approval Designation (AAD) to Nefecon -- -- Ministry of Food and Drug Safety in S...

 November 28, 2022 | News

WuXi AppTec Begins Construction of Wuxi STA Pharmaceutical East China R&D Facility

 WuXi AppTec recently held the groundbreaking ceremony for its Wuxi STA Pharmaceutical East China R&D facility in tandem with the signing ceremony...

 November 24, 2022 | News

Cellworks Therapy Biosimulation Study Reveals Promising New Biomarkers for TMZ Resistance in Glioblastoma Patients

Cellworks Group Inc., a leader in Precision Drug Development and Personalized Therapy Biosimulation, today announced results from a Cellworks biosimulation...

 November 23, 2022 | News

Merck to Acquire Imago BioSciences, Inc.

 Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO) today announce...

 November 22, 2022 | News

GSK opens first-in-Singapore high potency manufacturing and testing facility for next generation cancer treatments

S$44m investment in the new high potency manufacturing facility and laboratory further strengthens Jurong site capabilities to launch new products more q...

 November 21, 2022 | News

Ascletis Announces IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors by China NMPA

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today the approval of the Investigational New Drug (IND) application by China National Medical Prod...

 November 17, 2022 | News

BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in Singapore

First mRNA manufacturing facility in Singapore will create regional manufacturing capacities in support of BioNTech’s growing pipeline of...

 November 14, 2022 | News

Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis

Selinexor was granted orphan drug designation in MF by the U. S. Food and Drug Administration (FDA) in May 2022. Karyopharm is currently evaluating se...

 November 02, 2022 | News

Why Pharma and Medtech Should Digitize Quality in a Down Market

 We tend to put off investments in improvements and instead opt to play it safe, taking a conservative approach to weathering the economic storm. For ...

 November 01, 2022 | News | By Michelle Tanner, CFO, MasterControl

Gerresheimer and Merck Transform Primary Packaging into Digital Twins

Proof of Concept (PoC) successfully provides primary packaging with a unique ID to access its own trustworthy digital twin Users gain immediate access t...

 October 31, 2022 | News

Ardigen supports JUMP-CP Consortium to transform drug discovery with Cell Painting technology

The JUMP-CP Consortium’s aim is to validate and scale up image-based drug discovery strategies by creating the world’s largest public cel...

 October 28, 2022 | News

Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement

Sumitovant Biopharma Ltd. ("Sumitovant"), in conjunction with parent company Sumitomo Pharma Co., Ltd. ("Sumitomo Pharma"), and Myovant Sciences ("Myovant"...

 October 24, 2022 | News

Aragen to open a new formulation manufacturing facility

Facility will enhance Aragen’s offerings in clinical formulation development and manufacturing Will offer both integrated and stand-alone formulat...

 October 21, 2022 | News

SIRIO Launches Two Novel Gummies at CPHI Frankfurt

SIRIO Pharma (SIRIO) – the global nutraceutical contract development and manufacturing organization (CDMO) – launches two new gummies at&n...

 October 20, 2022 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close